Semler Scientific Inc. (SMLR)
Company Description
Semler Scientific, Inc. provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers in the United States.
The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.
Its products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, and family practitioners, as well as healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups.
The company offers its products through salespersons and distributors.
Semler Scientific, Inc. was incorporated in 2007 and is headquartered in Santa Clara, California.

Country | United States |
IPO Date | Feb 21, 2014 |
Industry | Medical - Devices |
Sector | Healthcare |
Employees | 79 |
CEO | Dr. Douglas Murphy-Chutorian M.D. |
Contact Details
Address: 2340-2348 Walsh Avenue Santa Clara, California United States | |
Website | https://www.semlerscientific.com |
Stock Details
Ticker Symbol | SMLR |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001554859 |
CUSIP Number | 81684M104 |
ISIN Number | US81684M1045 |
Employer ID | 26-1367393 |
SIC Code | 3845 |
Key Executives
Name | Position |
---|---|
Dr. Douglas Murphy-Chutorian M.D. | Chief Executive Officer, President & Director |
Jennifer Oliva Herrington | Chief Operating Officer |
Renae Cormier | Chief Financial Officer, Principal Accounting Officer, Head of Corporation Communications & Bus. Strategy and Secretary |
Shane Reid | Chief Technology Officer |
Cindy Guinasso | Senior Vice President of Business Development |
Dr. Herbert J. Semler | Founder & Chairman Emeritus |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Feb 28, 2025 | S-8 | Filing |
Feb 28, 2025 | 10-K | Annual Report |
Feb 18, 2025 | 8-K | Current Report |
Feb 14, 2025 | SCHEDULE 13G | Filing |
Feb 13, 2025 | SCHEDULE 13G/A | [Amend] Filing |
Feb 04, 2025 | 8-K | Current Report |
Feb 03, 2025 | SCHEDULE 13G/A | [Amend] Filing |
Jan 28, 2025 | 8-K | Current Report |
Jan 24, 2025 | 8-K | Current Report |
Jan 23, 2025 | 8-K | Current Report |